title: Prognostic factors in prostate cancer. Key elements in structured histopathology reporting of radical prostatectomy specimens.
abstract: Prostate cancer is the most common visceral cancer and the second most common cause of cancer death in males. The number of radical prostatectomies performed each year is increasing and accurate data from the histopathological examination of these specimens aid clinicians in stratifying patients for surveillance and adjuvant therapies. This review focuses on the histopathological prognostic factors which should be routinely recorded in pathology reports and complements the Royal College of Pathologists of Australasia Structured Reporting Protocol for Prostate Cancer (Radical Prostatectomy). Such structured pathology reports have been shown to significantly enhance the completeness and quality of data provided to clinicians. The review also discusses the International Society for Urological Pathology Consensus Conference recommendations which were published recently.
authors.affiliation: Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Sydney, Australia. james.kench@sswahs.nsw.gov.au
authors.forename: James G
authors.initials: JG
authors.lastname: Kench
authors.forename: David R
authors.initials: DR
authors.lastname: Clouston
authors.forename: Warick
authors.initials: W
authors.lastname: Delprado
authors.forename: Thomas
authors.initials: T
authors.lastname: Eade
authors.forename: David
authors.initials: D
authors.lastname: Ellis
authors.forename: Lisa G
authors.initials: LG
authors.lastname: Horvath
authors.forename: Hemamali
authors.initials: H
authors.lastname: Samaratunga
authors.forename: Jurgen
authors.initials: J
authors.lastname: Stahl
authors.forename: Alan M F
authors.initials: AM
authors.lastname: Stapleton
authors.forename: Lars
authors.initials: L
authors.lastname: Egevad
authors.forename: John R
authors.initials: JR
authors.lastname: Srigley
authors.forename: Brett
authors.initials: B
authors.lastname: Delahunt
mesh_terms: D000230:Adenocarcinoma / Q000556:secondary* / Q000601:surgery; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology; D008207:Lymphatic Metastasis; D008297:Male; D009361:Neoplasm Invasiveness; D011379:Prognosis; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000473:pathology* / Q000601:surgery; D012669:Seminal Vesicles / Q000473:pathology